These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 35091680)
21. Replication Study: The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Showalter MR; Hatakeyama J; Cajka T; VanderVorst K; Carraway KL; Fiehn O; Elife; 2017 Jun; 6():. PubMed ID: 28653623 [TBL] [Abstract][Full Text] [Related]
22. Isocitrate dehydrogenase mutations in myeloid malignancies. Medeiros BC; Fathi AT; DiNardo CD; Pollyea DA; Chan SM; Swords R Leukemia; 2017 Feb; 31(2):272-281. PubMed ID: 27721426 [TBL] [Abstract][Full Text] [Related]
23. The role of mutant IDH1 and IDH2 inhibitors in the treatment of acute myeloid leukemia. Nassereddine S; Lap CJ; Haroun F; Tabbara I Ann Hematol; 2017 Dec; 96(12):1983-1991. PubMed ID: 29090344 [TBL] [Abstract][Full Text] [Related]
25. Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations. Gross S; Cairns RA; Minden MD; Driggers EM; Bittinger MA; Jang HG; Sasaki M; Jin S; Schenkein DP; Su SM; Dang L; Fantin VR; Mak TW J Exp Med; 2010 Feb; 207(2):339-44. PubMed ID: 20142433 [TBL] [Abstract][Full Text] [Related]
26. Differential impact of IDH1/2 mutational subclasses on outcome in adult AML: results from a large multicenter study. Middeke JM; Metzeler KH; Röllig C; Krämer M; Eckardt JN; Stasik S; Greif PA; Spiekermann K; Rothenberg-Thurley M; Krug U; Braess J; Krämer A; Hochhaus A; Brümmendorf TH; Naumann R; Steffen B; Einsele H; Schaich M; Burchert A; Neubauer A; Görlich D; Sauerland C; Schäfer-Eckart K; Schliemann C; Krause SW; Hänel M; Frickhofen N; Noppeney R; Kaiser U; Kaufmann M; Kunadt D; Wörmann B; Sockel K; von Bonin M; Herold T; Müller-Tidow C; Platzbecker U; Berdel WE; Serve H; Baldus CD; Ehninger G; Schetelig J; Hiddemann W; Bornhäuser M; Stölzel F; Thiede C Blood Adv; 2022 Mar; 6(5):1394-1405. PubMed ID: 34794176 [TBL] [Abstract][Full Text] [Related]
27. [Analysis of IDH1 and IDH2 mutations in patients with acute myeloid leukemia]. Jia ZX; Zhou M; Chao HY; Lu XZ; Zhang R; Cen L; Xiao R; Jiang NK Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):397-401. PubMed ID: 22781800 [TBL] [Abstract][Full Text] [Related]
28. Outcomes for Patients With IDH-Mutated Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation. Chen EC; Li S; Eisfeld AK; Luskin MR; Mims A; Jones D; Antin JH; Cutler CS; Koreth J; Ho VT; Gooptu M; Romee R; El-Jawahri A; McAfee SL; DeFilipp Z; Soiffer RJ; Chen YB; Fathi AT Transplant Cell Ther; 2021 Jun; 27(6):479.e1-479.e7. PubMed ID: 33840625 [TBL] [Abstract][Full Text] [Related]